<result><Target><Item><Target_ID> 1800</Target_ID>
<Target_Name>Human blood-brain barrier (BBB) cellular model</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The human blood-brain barrier (BBB) cellular model was developed in Prof. Cecchelli’s laboratory and this model consists of a co-culture of human brain capillary endothelial cells derived from pluripotent stem cells and bovine pericytes on semi-permeable membranes of a transwell.</Comments>
</Item><Item><Target_ID> 1801</Target_ID>
<Target_Name>The envelope protein Ampho4070A</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1802</Target_ID>
<Target_Name>The cell surface of multidrug resistant Listeria monocytogenes</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Listeria monocytogenes:1639</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1803</Target_ID>
<Target_Name>Deinagkistrodon acutus venom</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Deinagkistrodon acutus:36307</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Lyophilized D. acutus venom was obtained from snake farms inYingtan, Jiangxi, China.</Comments>
</Item><Item><Target_ID> 1804</Target_ID>
<Target_Name>Mammary adenocarcinoma murine 4T1 cell line</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Mammary adenocarcinoma murine 4T1 cell line was kindly provided by Dr. João Nuno Moreira, from Centre for Neuroscience and Cell Biology(University of Coimbra, Portugal).</Comments>
</Item><Item><Target_ID> 1805</Target_ID>
<Target_Name>Traumatic brain injury (TBI)</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1806</Target_ID>
<Target_Name>Anti-Salmonella Typhimurium polyclonal antibody IgY</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Gallus gallus (Chicken):9031</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1807</Target_ID>
<Target_Name>Staphylococcus aureus biofilm</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Staphylococcus aureus：196620</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1808</Target_ID>
<Target_Name>Lambda fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM023</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1809</Target_ID>
<Target_Name>Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM025</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1810</Target_ID>
<Target_Name>Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM031</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1811</Target_ID>
<Target_Name>Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM040</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1812</Target_ID>
<Target_Name>Lambda fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM040</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1813</Target_ID>
<Target_Name>Lambda fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM041</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1814</Target_ID>
<Target_Name>Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM043</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1815</Target_ID>
<Target_Name>Lambda fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM043</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1816</Target_ID>
<Target_Name>Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM045</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1817</Target_ID>
<Target_Name>Lambda fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM045</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1818</Target_ID>
<Target_Name>Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM046</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1819</Target_ID>
<Target_Name>Lambda fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM046</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1820</Target_ID>
<Target_Name>Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM047</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1821</Target_ID>
<Target_Name>Lambda fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM047</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1822</Target_ID>
<Target_Name>Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM051</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1823</Target_ID>
<Target_Name>Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM035</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1824</Target_ID>
<Target_Name>Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM077</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item></Target></result>